Bioxcel Therapeutics Stock Forecast

Sell candidate since Jul 06, 2026 Loss -19.80%

The BioXcel Therapeutics Inc. stock price gained 7.91% on the last trading day (Monday, 13th Jul 2026), rising from $0.82 to $0.88. During the last trading day the stock fluctuated 14.69% from a day low at $0.81 to a day high of $0.93. The price has been going up and down for this period, and there has been a -32.66% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 733 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.27 million.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $0.80 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect BioXcel Therapeutics Inc. stock with a 90% probability to be traded between $0.799 and $1.41 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

BTAI Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 9.97%. Further rise is indicated until a new top pivot has been found. BioXcel Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioXcel Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.98 and $1.17. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for BioXcel Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.84 and $0.82. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioXcel Therapeutics Inc. finds support just below today's level at $0.84. If this is broken, then the next support from accumulated volume will be at $0.82 and $0.80.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.119 between high and low, or 14.69%. For the last week, the stock has had daily average volatility of 16.48%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BTAI) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect BioXcel Therapeutics Inc. to open at $0.87, and during the day (based on 14 day Average True Range), to move between $0.83 and $0.94, which gives a possible trading interval of +/-$0.107 (+/-12.94%) up or down from last closing price. If BioXcel Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.84 (5.03%) than the resistance at $1.04 (17.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioXcel Therapeutics Inc. stock A Buy?

BioXcel Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.191 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.87 ( 0.96%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk